Source: International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)"
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M.K. Han (Ann Arbor, United States of America). The microbiome in IPF. International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)"

Member's Comments

No comment yet.

Related content which might interest you: The bronchiectasis microbiome Source: Eur Respir Monogr 2018; 81: 82-98 Year: 2018 The microbiome in bronchiectasis Source: ERS Lung Science Conference 2019 Year: 2019 The lower airways microbiome in patients with IPF and COPD Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Gut microbiome in COPD Source: International Congress 2016 – Microbiome in health and in disease Year: 2016 The microbiome in interstitial lung disease Source: Lung Science Conference 2015 Year: 2015 The pulmonary microbiome and immunological activity in IPF patients. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 The study of airway microbiome and mycobiome of COPD and AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Immunometabolic markers and the sputum microbiome in bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021 The fungal microbiome and its role in bronchiectasis Source: International Congress 2019 – State of the art session: Respiratory infections Year: 2019 Lung microbiome dysbiosis is associated with mortality in COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 IPF Source: Eur Respir Monogr 2017; 77: 199-223 Year: 2017 IPF Source: Eur Respir Monogr 2017; 77: 58-65 Year: 2017 Ivacaftor/lumacaftor changes the lung microbiome and metabolome in cystic fibrosis patients Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI Year: 2020 Oral presentation: A comparative analysis of bacterial phylotypes of the lung microbiota of healthy, IPF and transplanted lungs Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Severity-related microbiome changes in COPD Source: Annual Congress 2013 –COPD and infections Year: 2013 The impact of smoking on airway microbiome and mycobiome of COPD/AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Inflammasome activation in airway macrophages and the lung microbiome in IPF Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 The microbiome of COPD in protected, bronchoscopic airway samples Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Lung microbiome dynamics in COPD exacerbations Source: Eur Respir J 2016; 47: 1082-1092 Year: 2016